Second to fourth digit ratio: a predictor of prostate-specific antigen level and the presence of prostate cancer

被引:35
|
作者
Jung, Han [1 ]
Kim, Khae Hawn [1 ]
Yoon, Sang Jin [1 ]
Kim, Tae Beom [1 ]
机构
[1] Gachon Univ Gil Hosp, Dept Urol, Inchon 405760, South Korea
关键词
Digit ratio; prostate volume; prostate-specific antigen; prostate cancer; ANDROGEN RECEPTOR GENE; RACIAL-DIFFERENCES; CAG REPEAT; AFRICAN-AMERICAN; FINGER-LENGTH; SEXUAL SELECTION; MEN; TESTOSTERONE; HYPERPLASIA; HORMONE;
D O I
10.1111/j.1464-410X.2010.09490.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
What's known on the subject? and What does the study add? The Homeobox genes, Hox a and d, control urinogenital system differentiation and digit development. The patterns of digit formation may be related to gonad function and may be reflected in 2nd to 4th digit ratio (digit ratio). Digit ratio is negatively correlated with prenatal testosterone levels and androgen receptor activity which is related to the increased prostate cancer risk. Patients with a lower digit ratio have a higher risk of prostate biopsy due to high PSA level, and of prostate cancer. Digit ratio could be a predictor of high PSA level and the presence of prostate cancer. OBJECTIVE To investigate the relationships between the 2nd to 4th digit ratio (digit ratio) and prostate volume, prostate-specific antigen (PSA) level, and the presence of prostate cancer. PATIENTS AND METHODS Of the men that presented with lower urinary tract symptoms (LUTS) at a single tertiary academic center, 366 men aged 40 or older with a PSA level < 40 ng/mL were prospectively enrolled. Right-hand 2nd and 4th digit lengths were measured prior to the PSA determinations and transrectal ultrasonography (TRUS). Prostate volumes were measured by TRUS without information about digit length. Patients with a PSA level >= 3 ng/mL underwent prostate biopsy. RESULTS No relationship was found between prostate volume and digit ratio [correlation coefficient (r) = -0.038, P = 0.466]. But, significant negative correlations were found between digit ratio and PSA (r = -0.140, P = 0.007). When the patients were divided into two groups (Group A: digit ratio < 0.95, n = 184; Group B: digit ratio >= 0.95, n = 182), Group A had a higher mean PSA level than Group B (3.26 +/- 5.54 ng/mL vs 1.89 +/- 2.24 ng/mL, P = 0.002) and had significantly higher risks of prostate biopsy [odds ratio (OR) = 1.75, 95% CI = 1.07-2.84] and prostate cancer (OR = 3.22, 95% CI = 1.33-7.78). CONCLUSIONS Patients with a lower digit ratio have higher risks of prostate biopsy and prostate cancer.
引用
收藏
页码:591 / 596
页数:6
相关论文
共 50 条
  • [31] Prostate-specific antigen and early detection of prostate cancer
    Chu, TM
    TUMOR BIOLOGY, 1997, 18 (02) : 123 - 134
  • [32] The case for prostate cancer screening with prostate-specific antigen
    Andriole, Gerald
    Djavan, Bob
    Fleshner, Neil
    Schroder, Fritz
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (12) : 737 - 745
  • [33] Prostate-Specific Antigen Doubling Time as a Predictor of Gleason Grade in Prostate Cancer
    Nowroozi, Mohammad Reza
    Zeighami, Shahryar
    Ayati, Mohsen
    Jamshidian, Hassan
    Ranjbaran, Ali Reza
    Moradi, Asaad
    Afsar, Firuzeh
    UROLOGY JOURNAL, 2009, 6 (01) : 27 - 30
  • [34] Prostate-Specific Antigen, Prostate Cancer, and Disorders of Hemostasis
    Lippi, Giuseppe
    Plebani, Mario
    Franchini, Massimo
    Guidi, Gian Cesare
    Favaloro, Emmanuel J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (07) : 654 - 664
  • [35] Metastatic prostate cancer with normal level of serum prostate-specific antigen
    R. Nishio
    Y. Furuya
    O. Nagakawa
    H. Fuse
    International Urology and Nephrology, 2003, 35 (2) : 189 - 192
  • [36] Role of serum prostate-specific antigen as predictor for bone metastases in newly diagnosed prostate cancer
    Singh, O. P.
    Yogi, Veenita
    Redhu, Pallavi
    Ghori, H. U.
    Pareek, Ananya
    Lal, Nancy
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 : S39 - S41
  • [37] The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality
    V. Stone, Benjamin
    Labban, Muhieddine
    Beatrici, Edoardo
    Filipas, Dejan K.
    D'Amico, Anthony, V
    Lipsitz, Stuart R.
    Choueiri, Toni K.
    Kibel, Adam S.
    Cole, Alexander P.
    Iyer, Hari S.
    Trinh, Quoc-Dien
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 563 - 569
  • [38] Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer
    Botchorishvili, George
    Matikainen, Mika P.
    Lilja, Hans
    CURRENT OPINION IN UROLOGY, 2009, 19 (03) : 221 - 226
  • [39] Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer
    Schroeder, Fritz H.
    Roobol, Monique J.
    CURRENT OPINION IN UROLOGY, 2009, 19 (03) : 227 - 231
  • [40] Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer
    MacKintosh, F. Roy
    Sprenkle, Preston C.
    Walter, Louise C.
    Rawson, Lori
    Karnes, R. Jeffrey
    Morrell, Christopher H.
    Kattan, Michael W.
    Nawaf, Cayce B.
    Neville, Thomas B.
    FRONTIERS IN ONCOLOGY, 2016, 6